-
Most Recent
Search Results
240 results for NOVL
8 Biotechnology Stocks to Sell Now
The overall ratings of eight biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
Borders Attempts to Compete with Kindle Through Kobo E-Reader
Borders’ plans to open a number of temporary retail outlets in small cities throughout the holiday season, the company is launching their own e-reader device…
Biotech M&A: Sanofi SA (ADR) Inks 2nd Multi-Billion Dollar Deal in a Week
Sanofi (SNY) inks second multi-dollar deal this month. Since the earlier deal last Monday, SNY stock gained 2.6% in a week.
Thursday’s Apple Rumors: Google’s Had it With That Meddling Apple
Google senior vice president claims Apple, Microsoft and others are snatching up patents in an “organized campaign against Android.”
9 Hot Europe Stocks Leading the EU Rally
After a brutal week on Wall Street sparked by rising fears over budget troubles in Europe, a concerted and focused bailout effort announced over the…
NBL Broke Below Up-Trending Support and Could Head Lower
We are opening a new bearish trade on Noble Energy, Inc. (NYSE:NBL).
Walmart Black Friday Ad 2018: 10 Top Deals to Expect
The Walmart Black Friday ad 2018 is out and it includes a look at deals customers can expect starting on Nov. 21 through Nov. 23.
13 Energy Equipment & Services Stocks to Sell Now
The overall ratings of 13 Energy Equipment & Services stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or…
Don’t Let Political Catalysts Cloud Your Judgment on Aurora Cannabis
Marijuana stocks are broadly showing signs of life, and ACB stock is no exception to this. Yet, there are reasons to exercise caution now.
The Test Has Begun
If you haven’t yet protected your portfolio by holding Ultra-Short ETFs, you may want to quickly establish a position on any rally. The test has…
Carnival Stock Will Survive and Thrive Even Without a Bailout
Investors expect Carnival to face steep losses ahead, as the coronavirus impacts demand. But CCL will survive and thrive in the long term.
Did Seattle’s Move on the Hourly Wage Make Lyft Uninvestable?
Seattle passed a minimum hourly wage of $16.39 for Lyft drivers. If you own Lyft stock get used to this kind of thing happening worldwide.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We’re starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today!
New Apple High Amid the Dips — Tuesday’s IP Market Recap
While the major indexes slipped back after Monday’s jump, Apple set yet another record.
National-Oilwell Varco, Inc.: 89% Dividend Cut Doesn’t Affect Bull Case for NOV
Unlike most companies, NOV has smartly allocated capital, including buying back NOV stock. Investors are smart to follow National-Oilwell’s lead.
Despite Strong Gains, Carnival Remains Attractive Longer Term
Carnival shares gained 31% in the past three months. Yet CCL stock sits at one-third its value from its all-time high of $72.70. Time to…
Ocugen Stock Very Well May Have Bottomed Out Here
I don’t know if InvestorPlace’s Larry Ramer is still short. But if he is, he’s made a few bucks with OCGN stock down 23% in…
VRTX Stock: The Disappointing News Sending Vertex Pharma Shares Lower
Vertex Pharma (VRTX) stock is dropping on Friday following the release of results from a Phase 2 clinical trial for VX-864.
Moody’s, McGraw-Hill Still Don’t Rate
If the Europe crisis really is resolved, both could enjoy a business rebound. However, Moody’s (MCO) still would be an expensive way to buy that…
Alphabet Could Learn Something From Its Failed Moonshot
Alphabet’s so-call “Other Bets” may never be big contributors to the fortunes of GOOG stock. But that’s not a reason to stop taking the moon…
‘To Kill a Mockingbird’ Sequel Coming July 2015
The ‘To Kill a Mockingbird’ sequel is coming this summer. Harper Lee’s classic novel was released in 1960.
5 Pharma Stocks That Could Double or Triple!
Emerging healthcare companies with novel technologies and drugs is where major growth prospects reside.
7 – 10 of 240 results
